Through research in the Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic is leading scientific advances in multiple sclerosis treatment.

It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...

Autoimmune encephalitis is a complex category of disease with diverse immunological associations and clinical manifestations. The Center for Multiple Sclerosis and Autoimmune Neurology is recognized ...

The Center for Multiple Sclerosis and Autoimmune Neurology is advancing the use of stem cells in neurological conditions. In stem cell therapy, young cells derived from bone marrow are used to treat ...

Researchers in the Pancreatic Cancer Early Detection Research Program are using multiple approaches to develop new tools for the early detection of pancreatic cancer, collaborating not only within our ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

Mayo Clinic cares for nearly 1,100 people with pancreatic cancer each year. In addition, the High-Risk Pancreas Clinic offers people at high risk of developing pancreatic cancer an evaluation and ...

In this research project, investigators in the Mayo Clinic Ovarian Cancer SPORE are exploring natural killer (NK) cells as an adoptive cellular therapy for cancer.

CCaTS may grant no-cost extensions to Benefactor-Funded Research Established-Investigator Career Development Awards.

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...